Position in GH
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$318,063
New position
Shares Held
2,120
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#408
of 593 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Savvy Advisors, Inc. holds $3,865,622 across 7 Diagnostics & Research names. GH ranks #5 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,084 | $1,044,834 | |
| 2 | DGX |
Quest Diagnostics Inc
|
3,847 | $815,371 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,265 | $665,946 | |
| 4 | DHR |
Danaher Corp /De/
|
2,681 | $510,676 | |
| 5 | GH |
Guardant Health, Inc.
This page
|
2,120 | $318,063 | |
| 6 | TWST |
Twist Bioscience Corp
|
2,511 | $258,331 | |
| 7 | WAT |
Waters Corp /De/
|
673 | $252,401 |
All Filings in GH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $318,063 | 2,120 | Shares | Sole | 2026-08-03 | |
| No filing history on record for this holder in this stock. | ||||||